In this study, we used label-free live cell imaging coupled with a fluorescent reporter of BRN2 promoter activity to monitor the kinetics of phenotype switching in primary human melanocytes and melanoma cells in homeostatic conditions. This evidence concerns the gene POU3F2 and melanoma.